Caraco Pharmaceutical Laboratories has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final approval from the FDA. Nicardipine Hydrochloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD 170 million in the US. :theflyonthewall.com
News For CPD From The Last 14 Days
Check below for free stories on CPD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
